Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

被引：39
|
作者：
Christie, S
Göbel, H
Mateos, V
Allen, C
Vrijens, F
Shivaprakash, M
机构：
[1] Merck & Co Inc, Dept WS3C 90, Whitehouse Stn, NJ 08889 USA
[2] Ottawa Headache Ctr, Ottawa, ON, Canada
[3] Univ Kiel, Kiel Pain Clin, Kiel, Germany
[4] Ctr Hosp Asturias, Dept Neurol, Oviedo, Spain
[5] Merck Sharp & Dohme Europe, Brussels, Belgium
来源：
EUROPEAN NEUROLOGY | 2003年 / 49卷 / 01期
关键词：
rizatriptan; ergotamine; efficacy; preference; migraine;
D O I：
10.1159/000067018
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：20 / 29
页数：10
相关论文
共 50 条
  • [21] Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks
    Le Jeunne, C
    Gómez, JP
    Pradalier, A
    Albareda, FT
    Joffroy, A
    Liaño, H
    Henry, P
    Lainez, JM
    Geraud, G
    EUROPEAN NEUROLOGY, 1999, 41 (01) : 37 - 43
  • [22] Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education on Treatment Response
    Cady, Roger K.
    Martin, Vincent T.
    Geraud, Gilles
    Rodgers, Anthony
    Zhang, Ying
    Ho, Andrew P.
    Hustad, Carolyn M.
    Ho, Tony W.
    Connor, Kathryn M.
    Ramsey, Karen E.
    HEADACHE, 2009, 49 (05): : 687 - 696
  • [23] Double-blind, multicentric, comparative study of lysin acetilsalicylate (1620 mg equivalent to 900 mg aspirin) plus metoclopramide (10 mg) versus ergotamine (2 mg) plus caffeine (200 mg) in the treatment of migraine.
    Titus, F
    Láinez, JM
    Leira, R
    Díez, E
    Monteiro, P
    Dexeus, I
    General, H
    Xeral, H
    Compostela, S
    La Paz, H
    Santo António, H
    CEPHALALGIA, 1999, 19 (04) : 371 - 372
  • [24] Patient preference in migraine therapy: A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan
    Díez F.I.
    Straube A.
    Zanchin G.
    Journal of Neurology, 2007, 254 (2) : 242 - 249
  • [25] Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy
    Lainez, M. J. A.
    Galvan, J.
    Heras, J.
    Vila, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (03) : 269 - 275
  • [26] Rizatriptan 10 mg improves functioning regardless of previous disability status in migraine patients
    Lopez-Gil, A
    Iparraguirre, ST
    Perez, MAF
    Gutierrez, EP
    Panadero, FJ
    CEPHALALGIA, 2003, 23 (07) : 713 - 713
  • [27] Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets
    Kolodny, A
    Polis, A
    Battisti, WP
    Johnson-Pratt, L
    Skobieranda, F
    CEPHALALGIA, 2004, 24 (07) : 540 - 546
  • [28] Efficacy and tolerability of rizatriptan rpd 10 mg in an open label randomized trial
    Gaul, C.
    Katsarava, Z.
    Gendolla, A.
    Diener, H. -C.
    CEPHALALGIA, 2011, 31 (01) : 50 - 50
  • [29] SUBLINGUAL FLUNARIZINE - A NEW EFFECTIVE MANAGEMENT OF THE MIGRAINE ATTACK - A COMPARISON VERSUS ERGOTAMINE
    BONUSO, S
    DISTASIO, E
    MARANO, E
    SORGE, F
    LEO, A
    HEADACHE, 1986, 26 (05): : 227 - 230
  • [30] Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: A randomized, double-blind, crossover study
    Peroutka, SJ
    Lyon, JA
    Swarbrick, J
    Lipton, RB
    Kolodner, K
    Goldstein, J
    HEADACHE, 2004, 44 (02): : 136 - 141
12345